A standardization engine for advancing cell and gene therapy manufacturing

Xcell Therapeutics Inc.
Biopharma Dealmakers · Springer Nature · 2026-01-06 · DOI: 10.1038/d43747-026-00002-2

Abstract

Biopharma Dealmakers, Published online: 06 January 2026; doi:10.1038/d43747-026-00002-2 Xcell Therapeutics is developing completely animal-origin-free, chemically defined stem-cell media, enhancing safety, quality, and reproducibility.

Read at publisher →

Similar articles